Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Incontinence: should we inject the trigone during botulinum toxin injection?

× No keyword cloud information.

10 in total

1. Prospective randomised controlled trial comparing trigone-sparing versus trigone-including intradetrusor injection of abobotulinumtoxinA for refractory idiopathic detrusor overactivity.

Authors: Rustom P Manecksha; Ivor M Cullen; Sarfraz Ahmad; Graeme McNeill; Robert Flynn; Thomas E D McDermott; Ronald Grainger; John A Thornhill
Journal: Eur Urol Date: 2011-11-07 Impact factor: 20.096

2. Bladder base/trigone injection is safe and as effective as bladder body injection of onabotulinumtoxinA for idiopathic detrusor overactivity refractory to antimuscarinics.

Authors: Hann-Chorng Kuo
Journal: Neurourol Urodyn Date: 2011-05-10 Impact factor: 2.696

3. Intravesical instillation of botulinum toxin A: an in vivo murine study and pilot clinical trial.

Authors: Jan Krhut; Peter Zvara
Journal: Int Urol Nephrol Date: 2010-06-20 Impact factor: 2.370

4. Botulinum toxin type a injections into the trigone to treat idiopathic overactive bladder do not induce vesicoureteral reflux.

Authors: Gilles Karsenty; Ehab Elzayat; Thomas Delapparent; Benoît St-Denis; Marie-Claude Lemieux; Jacques Corcos
Journal: J Urol Date: 2007-03 Impact factor: 7.450

5. Botulinum toxin-A injections into neurogenic overactive bladder--to include or exclude the trigone? A prospective, randomized, controlled trial.

Authors: Taha A Abdel-Meguid
Journal: J Urol Date: 2010-10-16 Impact factor: 7.450

6. Intravesical botulinum type A toxin injection in patients with overactive bladder: Trigone versus trigone-sparing injection.

Authors: Alvaro Lucioni; David E Rapp; Edward M Gong; Paula Fedunok; Gregory T Bales
Journal: Can J Urol Date: 2006-10 Impact factor: 1.344

7. Urodynamic and immunohistochemical evaluation of intravesical botulinum toxin A delivery using liposomes.

Authors: Yao-Chi Chuang; Pradeep Tyagi; Chao-Cheng Huang; Naoki Yoshimura; Moya Wu; Jonathan Kaufman; Michael B Chancellor
Journal: J Urol Date: 2009-06-18 Impact factor: 7.450

8. Trigonal injection of botulinum toxin-A does not cause vesicoureteral reflux in neurogenic patients.

Authors: Frederico Mascarenhas; Marcello Cocuzza; Cristiano Mendes Gomes; Nilo Leão
Journal: Neurourol Urodyn Date: 2008 Impact factor: 2.696

9. Comparison of effectiveness of detrusor, suburothelial and bladder base injections of botulinum toxin a for idiopathic detrusor overactivity.

Authors: Hann-Chorng Kuo
Journal: J Urol Date: 2007-08-16 Impact factor: 7.450

Review 10. Proposed mechanism for the efficacy of injected botulinum toxin in the treatment of human detrusor overactivity.

Authors: Apostolos Apostolidis; Prokar Dasgupta; Clare J Fowler
Journal: Eur Urol Date: 2006-01-04 Impact factor: 20.096

10 in total